?

Versi Jannine

Director
Adamis Pharmaceuticals Corporation
US, San Diego [HQ]
CIK 1977745

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
177,194
Price per Share :
$0.78
Equivalence :
$138,211.32

Transaction History

  • A
    Form 4
    177,194 Shares After Transaction
    Value : $n/a
    $0.0
    05/25/23
  • Footnotes:
    #1 On May 22, 2023, Adamis Pharmaceuticals Corporation ("Adamis") effected a 1 for 70 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
    #2 The reported shares are owned directly by Versi Group, LLC, of which the reporting person is the trustee of. The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interests therein.
    #3 Received in exchange for shares of common stock of DMK Pharmaceuticals Corporation, a privately held corporation ("DMK"), in connection with the merger of DMK into a subsidiary of Adamis (the "Merger"). On the effective date of the Merger, the closing price of Adamis common stock was $2.50 per share.